Tiziana Life Sciences annual capital expenditures (capex)
2016
2017
2019
2020
2021
2024
2025
Tiziana Life Sciences Capital Expenditures (CapEx) Growth & History (TLSA)
Tiziana Life Sciences's capital expenditures (capex) was $21,000 for fiscal 2025.
View full Tiziana Life Sciences company overviewTiziana Life Sciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $21,000 | $2,000 | +10.53% |
| 2024 | 2024-12-31 | $19,000 | — | — |
| 2021 | 2021-12-31 | $22,000 | $19,000 | +633.33% |
| 2020 | 2020-12-31 | $3,000 | −$1,000 | −25.00% |
| 2019 | 2019-12-31 | $4,000 | — | — |
| 2017 | 2017-12-31 | $1,000 | −$47,000 | −97.92% |
| 2016 | 2016-12-31 | $48,000 | — | — |
Tiziana Life Sciences capital expenditures (capex) trends
Over the last five fiscal years, Tiziana Life Sciences's capital expenditures (capex) increased from $3,000 to $21,000, a change of $18,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tiziana Life Sciences source filings ↗